市场调查报告书
商品编码
1463582
南美洲和中美洲牛诊断市场预测至 2030 年 - 区域分析 - 按产品、疾病类型和最终用户(兽医医院、兽医诊所和其他最终用户)South & Central America Bovine Diagnostics Market Forecast to 2030 - Regional Analysis - by Product, Disease Type, and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) |
南美洲和中美洲CAGR诊断市场预计将从2022年的1.1401亿美元成长到2030年的1.7957亿美元。
牛乳腺炎的高盛行率和经济影响推动了南美洲和中美洲牛诊断市场
牛乳腺炎是一个全球性问题,对全球农业部门带来巨大的经济损失。乳腺炎会导致受影响动物的产奶量下降,并导致持续的兽医费用,从而导致酪农的获利能力下降。根据赛默飞世尔科技 2022 年 7 月发布的估计,乳腺炎每年对全球乳製品行业造成的总成本在 197 亿美元至 320 亿美元之间。
根据2021 年4 月发表的研究《全球和全国范围内乳牛和水牛亚临床和临床乳房炎盛行率的系统性回顾和统合分析》,全球亚临床乳房炎(SCM) 和临床乳房炎(CM) 的汇总盛行率2011-2019 年期间分别为 42% 和 15%。由于乳製品行业中乳腺炎的历史较长,预计乳腺炎的盛行率将会增加。来自世界各地的事实和资料表明临床乳房炎的高盛行率,这引发了对牛诊断的需求。此外,不同国家政府引入的监测计划和良好的管理系统支持了牛隻诊断市场。
南美洲和中美洲牛诊断市场概述
南美洲和中美洲的牛隻诊断市场分为巴西、阿根廷以及南美洲和中美洲的其他地区。该地区市场成长的主要推动因素包括牛隻诊断工具和技术的进步、口蹄疫和结核病发病率的增加、以及为提高含牛肉食品品质而进行的牛隻诊断的增加。巴西在南美洲和中美洲牛诊断市场中占有最大份额。巴西是世界领先的畜牧业国家,饲养的牛隻数量最多。世界人口的成长和生活水准的提高推动了世界各地对肉类的需求。因此,对健康肉类的需求导致巴西牛诊断市场的成长。诊断技术的进步使得牛白血病病毒(BLV)的诊断和系统发育分析成为可能。巴西东北部马拉尼昂州的乳牛中存在明显的 BLV 感染,2022 年系统发育推断首次显示该地区存在基因型 6。该基因型与先前在巴西中西部和东南部样本中发现的基因序列有关。因此,BLV 和 EBL 诊断的开发工作于 2022 年启动,这推动了针对早期感染病例的白血病治疗方案的进展。地方性牛白血病(EBL)是一种广泛分布于牛群的慢性病毒性疾病,可能需要数年时间才能显现临床症状。因此,为了预防牛群中的流行病,诊断结果将使兽医卫生当局和畜牧养殖者能够采取初步行动。
南美洲和中美洲牛诊断市场收入及 2030 年预测(百万美元)
南美洲和中美洲牛诊断市场细分
南美洲和中美洲牛诊断市场按产品、疾病类型、最终用户和国家细分。
根据产品,南美洲和中美洲牛诊断市场分为免疫测定试剂盒、PCR 试剂和试剂盒、血凝抑制 (HI) 测定和其他产品。 2022 年,免疫分析试剂盒细分市场在南美洲和中美洲牛诊断市场中占据最大份额。
根据疾病类型,南美洲和中美洲牛诊断市场分为牛病毒性腹泻(BVD)、牛结核病(TB)、牛乳房炎、口蹄疫(FMD)和其他疾病类型。 2022 年,牛乳房炎细分市场在南美洲和中美洲牛诊断市场中占据最大份额。
根据最终用户,南美洲和中美洲牛诊断市场分为兽医医院、兽医诊所和其他最终用户。 2022 年,兽医院细分市场在南美洲和中美洲牛隻诊断市场中占据最大份额。
根据国家/地区,南美洲和中美洲牛诊断市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年,巴西将主导南美洲和中美洲牛隻诊断市场。
Idexx Laboratories Inc、bioMerieux SA、Innovative Diagnostics SAS、Neogen Corp 和 Thermo Fisher Scientific Inc 是南美洲和中美洲牛诊断市场的一些领先公司。
The South & Central America bovine diagnostics market is expected to grow from US$ 114.01 million in 2022 to US$ 179.57 million by 2030. It is estimated to grow at a CAGR of 5.8% from 2022 to 2030.
High Prevalence and Economic Impact of Bovine Mastitis Fuels South & Central America Bovine Diagnostics Market
Bovine mastitis is a global concern that incurs huge economic losses to the global agriculture sector. Mastitis results in lowered milk production in affected animals and causes continuous veterinary expenses, resulting in reduced profitability for dairy farmers. According to the estimates published by Thermo Fisher Scientific in July 2022, the total annual cost to the global dairy industry caused by mastitis is between US$ 19.7 billion to US$ 32 billion.
According to the study "Global and countrywide prevalence of subclinical and clinical mastitis in dairy cattle and buffaloes by systematic review and meta-analysis," published in April 2021, the global pooled prevalence of subclinical mastitis (SCM) and clinical mastitis (CM) were 42% and 15%, respectively, during 2011-2019. The prevalence of mastitis is expected to increase due to the prolonged history of the disease in the dairy industry. The facts and data from across the world indicate the high prevalence of clinical mastitis, which triggers the demand for bovine diagnostics. Moreover, surveillance programs and good management systems introduced by governments in different countries support the bovine diagnostics market.
South & Central America Bovine Diagnostics Market Overview
The bovine diagnostics market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is mainly driven by the factors such as advancements in bovine diagnostics tools and technologies, increasing incidences of foot and mouth diseases and bTB, and a rise in bovine diagnostics to enhance the quality of food products containing bovine meat. Brazil counts for the largest share of the bovine diagnostic market in South & Central America. Brazil is the world's leading livestock country, with the largest number of cattle grown. The growth of the world's population and improvements in living standards boost the demand for meat across the world. Therefore, the demand for healthy meats results in the growth of the bovine diagnostics market in Brazil. Technological progress in diagnostics has enabled the diagnosis and phylogenetic analysis of bovine leukemia virus (BLV). The BLV infection in dairy cattle was evident in Maranhao, Northeastern Brazil, and for the first time in 2022, phylogenetic inferences showed genotype 6 in this region. This genotype is related to gene sequences previously identified in samples from central-western and southeastern Brazil. Thus, the development efforts for BLV and EBL diagnosis were initiated in 2022, which has fueled progress in leukemia treatment options for the cases of infections that are in an early stage. Enzootic bovine leukosis (EBL) is a chronic viral disease widely distributed in cattle herds and may take several years to manifest clinical signs. Thus, to prevent the epidemic in cattle, the diagnosis would allow veterinary health authorities and animal farmers to take preliminary actions.
South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Bovine Diagnostics Market Segmentation
The South & Central America bovine diagnostics market is segmented into product, disease type, end user, and country.
Based on product, the South & Central America bovine diagnostics market is segmented into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The immunoassay kits segment held the largest share of the South & Central America bovine diagnostics market in 2022.
Based on disease type, the South & Central America bovine diagnostics market is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and other disease types. The bovine mastitis segment held the largest share of the South & Central America bovine diagnostics market in 2022.
Based on end user, the South & Central America bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end-users. The veterinary hospitals segment held the largest share of the South & Central America bovine diagnostics market in 2022.
Based on country, the South & Central America bovine diagnostics market is segmented int o Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bovine diagnostics market in 2022.
Idexx Laboratories Inc, bioMerieux SA, Innovative Diagnostics SAS, Neogen Corp, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America bovine diagnostics market.